AU Patent

AU2017315781B2 — Use of pridopidine for treating dystonias

Assigned to Prilenia Neurotherapeutics Ltd · Expires 2021-01-28 · 5y expired

What this patent protects

The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.

USPTO Abstract

The invention provides a method of treating a subject afflicted with a dystonia, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.

Drugs covered by this patent

Patent Metadata

Patent number: AU2017315781B2
Jurisdiction: AU
Classification: —
Expires: 2021-01-28
Drug substance claim: No
Drug product claim: No
Assignee: Prilenia Neurotherapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.